Towards cellular receptors for prions

Reviews in Medical Virology

Volumn 13, Issue 6, 2003, Pages 399-408

  Lee, Kil Sun ^a   Linden, Rafael ^b   Prado, Marco Antônio M ^c   Brentani, Ricardo R ^a,d   Martins, Vilma R ^a,d  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c ICB   (Brazil)

^d Hospital Do Câncer   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR PRION PROTEIN; INFECTIOUS PRION PROTEIN; ISOPROTEIN; LAMININ RECEPTOR; LIGAND; NERVE CELL ADHESION MOLECULE; PRION PROTEIN; PROTEIN X; UNCLASSIFIED DRUG;

CELL CULTURE; CELL FREE SYSTEM; CELL MEMBRANE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; COMPLEX FORMATION; DEGENERATIVE DISEASE; ENDOCYTOSIS; GENE MUTATION; HUMAN; IN VITRO STUDY; INTERNALIZATION; MACROMOLECULE; NONHUMAN; PATHOGENESIS; PRION DISEASE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW;

HUMANS; PRION DISEASES; PROTEIN ISOFORMS; PRPC PROTEINS; PRPSC PROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0242443377     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.408     Document Type: Review

References (91)

1. Weigel PH, Yik JH. Glycans as endocytosis signals: the cases of the asialoglycoprotein and hyaluronan/chondroitin sulfate receptors. Biochim Biophys Acta 2002; 1572: 341-363.
2. Hussain MM. Structural, biochemical and signaling properties of the low-density lipoprotein receptor gene family. Front Biosci 2001; 6: D417-D428.
3. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol 1998; 35: 35-54.
4. Giesen K, Lammel U, Langehans D, Krukkert K, Bunse I, Klambt C. Regulation of glial cell number and differentiation by ecdysone and Fos signaling. Mech Dev 2003; 120: 401-413.
5. Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol 2002; 67: 203-233.
6. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol 1995; 11: 549-599.
7. Schwartz MA, Ginsberg MH. Networks and cross-talk: integrin signalling spreads. Nat Cell Biol 2002; 4: E65-E68.
8. Arias CF, Guerrero CA, Mendez E, et al. Early events of rotavirus infection: the search for the receptor(s). Novartis Found Symp 2001; 238: 47-60.
9. Magdesian MH, Giordano R, Ulrich H, et al. Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor. J Biol Chem 2001; 276: 19382-19389.
10. Lopes JD, dos RM, Brentani RR. Presence of laminin receptors in Staphylococcus aureus. Science 1985; 229: 275-277.
11. Liu J, Shriver Z, Pope RM, et al. Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type I glycoprotein D. J Biol Chem 2002; 277: 33456-33467.
12. Baum J, Ward RH, Conway DJ. Natural selection on the erythrocyte surface. Mol Biol Evol 2002; 19: 223-229.
13. Joensen L, Borda E, Kohout T, Perry S, Garcia G, Sterin-Borda L. Trypanosoma cruzi antigen that interacts with the beta1-adrenergic receptor and modifies myocardial contractile activity. Mol Biochem Parasitol 2003; 127: 169-177.
14. Cloyd MW, Chen JJ, Adeqboyega P, Wang L. How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors. Curr Mol Med 2001; 1: 545-550.
15. Shyng SL, Heuser JE, Harris DA. A glycolipidanchored prion protein is endocytosed via clathrincoated pits. J Cell Biol 1994; 125: 1239-1250.
16. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-13383.
17. Brown DR. Mayhem of the multiple mechanisms: modelling neurodegeneration in prion disease. J Neurochem 2002; 82: 209-215.
18. Caughey B. Interactions between prion protein isoforms: the kiss of death? Trends Biochem Sci 2001; 26: 235-242.
19. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-925.
20. Bruce ME, Will RG, Ironside JW, et al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501.
21. Hill AF, Desbruslais M, Joiner S, et al. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-450, 526.
22. Henry C, Knight R. Clinical features of variant Creutzfeldt-Jakob disease. Rev Med Virol 2002; 12: 143-150.
23. Soto C. Altering prion replication for therapy and diagnosis of transmissible spongiform encephalopathies. Biochem Soc Trans 2002; 30: 569-574.
24. Griffiths PD. Preparing to treat prions. Rev Med Virol 2002; 12: 1-3.
25. Griffith JS. Self-replication and scrapie. Nature 1967; 215: 1043-1044.
26. Bueler H, Aguzzi A, Sailer A, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73: 1339-1347.
27. Meyer RK, Lustig A, Oesch B, Fatzer R, Zurbriggen A, Vandevelde M. A monomer-dimer equilibrium of a cellular prion protein (PrPC) not observed with recombinant PrP. J Biol Chem 2000; 275: 38081-38087.
28. Pan KM, Baldwin M, Nguyen J, et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 1993; 90: 10962-10966.
29. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266: 18217-18223.
30. Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 1998; 273: 32230-32235.
31. Peretz D, Williamson RA, Legname G, et al. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 2002; 34: 921-932.
32. Hill AF, Collinge J. Strain variations and species barriers. Contrib Microbiol 2001; 7: 48-57.
33. Korth C, Kaneko K, Groth D, et al. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci USA 2003; 100: 4784-4789.
34. Raymond GJ, Bossers A, Raymond LD, et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J 2000; 19: 4425-4430.
35. Aguzzi A. Blood simple prion diagnostics. Nat Med 2001; 7: 289-290.
36. Shyng SL, Huber MT, Harris DA. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J Biol Chem 1993; 268: 15922-15928.
37. Magalhaes AC, Silva JA, Lee KS, et al. Endocytic intermediates involved with the intracellular trafficking of a fluorescent cellular prion protein. J Biol Chem 2002; 277: 33311-33318.
38. Negro A, Ballarin C, Bertoli A, Massimino ML, Sorgato MC. The metabolism and imaging in live cells of the bovine prion protein in its native form or carrying single amino acid substitutions. Mol Cell Neurosci 2001; 17: 521-538.
39. Laine J, Marc ME, Sy MS, Axelrad H. Cellular and subcellular morphological localization of normal prion protein in rodent cerebellum. Eur J Neurosci 2001; 14: 47-56.
40. Prusiner SB. Molecular biology of prion diseases. Science 1991; 252: 1515-1522.
41. Ma J, Lindquist S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc Natl Acad Sci USA 2001; 98: 14955-14960.
42. Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002; 298: 1781-1785.
43. Yedidia Y, Horonchik L, Tzaban S, Yanai A, Taraboulos A. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J 2001; 20: 5383-5391.
44. Ivanova L, Barmada S, Kummer T, Harris DA. Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 2001; 276: 42409-42421.
45. Cohen E, Taraboulos A. Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells. EMBO J 2003; 22: 404-417.
46. Drisaldi B, Stewart RS, Adles C, et al. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation. J Biol Chem 2003; 278: 21732-21743.
47. Beranger F, Mange A, Goud B, Lehmann S. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells. J Biol Chem 2002; 277: 38972-38977.
48. Taraboulos A, Raeber AJ, Borchelt DR, Serban D, Prusiner SB. Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 1992; 3: 851-863.
49. Vey M, Pilkuhn S, Wille H, et al. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci USA 1996; 93: 14945-14949.
50. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 1997; 272: 6324-6331.
51. Kaneko K, Vey M, Scott M, Pilkuhn S, Cohen FE, Prusiner SB. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci USA 1997; 94: 2333-2338.
52. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J 2002; 21: 1031-1040.
53. Damke H, Baba T, Warnock DE, Schmid SL. Induction of mutant dynamin specifically blocks endocytic coated vesicle formation. J Cell Biol 1994; 127: 915-934.
54. Oh P, McIntosh DP, Schnitzer JE. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 1998; 141: 101-114.
55. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 1992; 267: 16188-16199.
56. McKinley MP, Taraboulos A, Kenaga L, et al. Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest 1991; 65: 622-630.
57. Arnold JE, Tipler C, Laszlo L, Hope J, Landon M, Mayer RJ. The abnormal isoform of the prion protein accumulates in late-endosome-like organelles in scrapie-infected mouse brain. J Pathol 1995; 176: 403-411.
58. Shyng SL, Moulder KL, Lesko A, Harris DA. The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrincoated pits. J Biol Chem 1995; 270: 14793-14800.
59. Lee KS, Magalhaes AC, Zanata SM, Brentani RR, Martins VR, Prado MA. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem 2001; 79: 79-87.
60. Flechsig E, Shmerling D, Hegyi I, et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 2000; 27: 399-408.
61. Horiuchi M, Baron GS, Xiong LW, Caughey B. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain. J Biol Chem 2001; 276: 15489-15497.
62. Perrier V, Kaneko K, Safar J, et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc Natl Acad Sci USA 2002; 99: 13079-13084.
63. Telling GC, Scott M, Mastrianni J, et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995; 83: 79-90.
64. Edenhofer F, Rieger R, Famulok M, Wendler W, Weiss S, Winnacker EL. Prion protein PrPc interacts with molecular chaperones of the Hsp60 family. J Virol 1996; 70: 4724-4728.
65. Stockel J, Hartl FU. Chaperonin-mediated de novo generation of prion protein aggregates. J Mol Biol 2001; 313: 861-872.
66. Cordeiro Y, Machado F, Juliano L, et al. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J Biol Chem 2001; 276: 49400-49409.
67. Derrington E, Gabus C, Leblanc P, et al. PrPC has nucleic acid chaperoning properties similar to the nucleocapsid protein of HIV-1. C R Acad Sci III 2002; 325: 17-23.
68. Priola SA, Caughey B. Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 1994; 8: 113-120.
69. Pan T, Wong BS, Liu T, Li R, Petersen RB, Sy MS. Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 2002; 368: 81-90.
70. Wong C, Xiong LW, Horiuchi M, et al. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J 2001; 20: 377-386.
71. Gauczynski S, Peyrin JM, Haik S, et al. The 37-kDa/ 67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 2001; 20: 5863-5875.
72. Graner E, Mercadante AF, Zanata SM, et al. Cellular prion protein binds laminin and mediates neuritogenesis. Brain Res Mol Brain Res 2000; 76: 85-92.
73. Graner E, Mercadante AF, Zanata SM, Martins VR, Jay DG, Brentani RR. Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein. FEBS Lett 2000; 482: 257-260.
74. Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A. Binding of disease-associated prion protein to plasminogen. Nature 2000; 408: 479-483.
75. Maissen M, Roeckl C, Glatzel M, Goldmann W, Aguzzi A. Plasminogen binds to disease-associated prion protein of multiple species. Lancet 2001; 357: 2026-2028.
76. Ellis V, Daniels M, Misra R, Brown D. Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner. Biochemistry 2002; 41: 6891-6896.
77. Schmitt-Ulms G, Legname G, Baldwin MA, et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001; 314: 1209-1225.
78. Yehiely F, Bamborough P, Da Costa M, et al. Identification of candidate proteins binding to prion protein. Neurobiol Dis 1997; 3: 339-355.
79. Hundt C, Peyrin JM, Haik S, et al. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J 2001; 20: 5876-5886.
80. Zanata SM, Lopes MH, Mercadante AF, et al. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J 2002; 21: 3307-3316.
81. Chiarini LB, Freitas AR, Zanata SM, Brentani RR, Martins VR, Linden R. Cellular prion protein transduces neuroprotective signals. EMBO J 2002; 21: 3317-3326.
82. Martins VR, Graner E, Garcia-Abreu J, et al. Complementary hydropathy identifies a cellular prion protein receptor. Nat Med 1997; 3: 1376-1382.
83. Chabry J, Caughey B, Chesebro B. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides. J Biol Chem 1998; 273: 13203-13207.
84. Lassle M, Blatch GL, Kundra V, Takatori T, Zetter BR. Stress-inducible, murine protein mSTI1. Characterization of binding domains for heat shock proteins and in vitro phosphorylation by different kinases. J Biol Chem 1997; 272: 1876-1884.
85. Spielhaupter C, Schatzl HM. PrPC directly interacts with proteins involved in signaling pathways. J Biol Chem 2001, 276: 44604-44612.
86. Della-Bianca V, Rossi F, Armato U, et al. Neurotrophin p75 receptor is involved in neuronal damage by prion peptide-(106-126). J Biol Chem 2001; 276: 38929-38933.
87. Mouillet-Richard S, Ermonval M, Chebassier C, et al. Signal transduction through prion protein. Science 2000; 289: 1925-1928.
88. Meggio F, Negro A, Sarno S, et al. Bovine prion protein as a modulator of protein kinase CK2. Biochem J 2000; 352: 191-196.
89. Jin T, Gu Y, Zanusso G, et al. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome. J Biol Chem 2000; 275: 38699-38704.
90. Oesch B, Teplow DB, Stahl N, Serban D, Hood LE, Prusiner SB. Identification of cellular proteins binding to the scrapie prion protein. Biochemistry 1990; 29: 5848-5855.
91. Kurschner C, Morgan JI. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res Mol Brain Res 1995; 30: 165-168.